
Roche Diabetes Care, Inc.
Free shipping on orders over $99 · 30-day returns
Accu-Chek Softclix Blood Lancing System is an FDA 510(k)-cleared medical device (K214022) manufactured by Roche Diabetes Care, Inc.. This device is classified under the General, Plastic Surgery specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on February 16, 2022. Regulation: 8.